Chinese-developed lung cancer treatment approved for NHS patients in England #coolchina

A Chinese-developed immunotherapy for one of the most aggressive forms of lung cancer is set to become available on England's National Health Service, marking a milestone for both patients and China's rapidly growing pharmaceutical industry.

The National Institute for Health and Care Excellence (NICE) has recommended Serplulimab (Hetronifly), developed by Shanghai-based biotechnology company Henlius, in combination with chemotherapy for eligible patients with extensive stage small cell lung cancer (SCLC).

SCLC is an aggressive form of lung cancer with limited treatment options and a poor prognosis.

#news #China #UK #science #research #cancer

📺 Subscribe to our YouTube channel and stay updated with our latest analysis and interviews:👇 https://www.youtube.com/channel/UCgrNz-aDmcr2uuto8_DL2jg 👈

Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8 Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv

For more: https://www.cgtn.com/video

Most watched videos: Impossible Challenge: 30 seconds to count banknotes BLINDFOLDED https://www.youtube.com/watch?v=ZmP_Ybj-jws Impossible Challenge: Gymnastics Boy Arat Hosseini from Iran! https://www.youtube.com/watch?v=8sxX--U4c8w Impossible Challenge: How to calm babies in 5 seconds? https://www.youtube.com/watch?v=kR3q9sXM7WA